[1]Vasileiou I, Xanthos T, Koudouna E, et al. Propofol: a review of its non-anaesthetic effects[J]. Eur J Pharmacol, 2009, 605: 1-8. [2]Wang ZT, Gong HY, Zheng F, et al. Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression[J]. Genet Mol Res, 2015, 14: 8117-8124. [3]Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells[J]. Int J Biochem Cell Biol, 2010, 43: 969-980. [4]Wang S, Ma Y, Wang P, et al. Knockdown of PKM2 enhances radiosensitivity of non-small cell lung cancer[J]. Cell Biochem Biophys, 2015, 73: 21-26. [5]Ren XF, Li WZ, Meng FY, et al. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients[J]. Anaesthesia, 2010, 65: 478-482. [6]Yang N, Liang Y, Yang P, et al. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression[J]. Brazi J Medi Biol Res, 2017, 50: e5794.doi: 10.1590/1414-431X20165794. [7]Ye HJ, Bai JJ, Guo PP, et al. Propofol suppresses invasion of human lung cancer A549 cells by down-regulating aquaporin-3 and matrix metalloproteinase-9[J]. J South Medil Unive, 2016, 36:1286-1290. [8]Liu WZ, Liu N. Propofol inhibits lung cancer A549 cells growth and epithelial-mesenchymal transition process by up-regulation of microRNA-1284[J]. Oncol Res, 2018, 27: 1-8. [9]Ferguson EC, Rathmell JC. New roles for pyruvate kinase M2: working out the Warburg effect[J]. Trends Bioche Sci, 2008, 33: 359-362. [10]Dombrauckas JD, Santarsiero BD, Mesecar AD. Struc-tural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis[J]. Bioch, 2005, 44: 9417-9429. [11]Noguchi T, Inoue H, Tanaka T. The M1-and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing[J]. J Biol Chemi, 1986, 261: 13807-13812. [12]Wong N, De Melo J, Tang D. PKM2, a central point of regulation in cancer metabolism[J]. Int J Cell Biol, 2013, 14: 1-11. [13]Sun H, Zhu A, Zhang L, et al. Knockdown of PKM2 suppresses tumor growth and invasion in lung adenocarcinoma[J]. Intern J Molec Sci, 2015, 16: 24574-24587. [14]Parnell M, Foulks JM, Nix R, et al. Abstract 3226: PKM2 metabolic activator slows lung cancer xenograft growth[J]. Cancer Res, 2012, 72: 3226-3226. |